Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial

Thang Nguyen, Thao H Nguyen, Phu T Nguyen, Ha T Tran, Ngoc V Nguyen, Hoa Q Nguyen, Ban N Ha, Tam T Pham, Katja Taxis, Thang Nguyen, Thao H Nguyen, Phu T Nguyen, Ha T Tran, Ngoc V Nguyen, Hoa Q Nguyen, Ban N Ha, Tam T Pham, Katja Taxis

Abstract

Background: Patient adherence to cardioprotective medications improves outcomes of acute coronary syndrome (ACS), but few adherence-enhancing interventions have been tested in low-income and middle-income countries. Objectives: We aimed to assess whether a pharmacist-led intervention enhances medication adherence in patients with ACS and reduces mortality and hospital readmission. Methods: We conducted a randomized controlled trial in Vietnam. Patients with ACS were recruited, randomized to the intervention or usual care prior to discharge, and followed 3 months after discharge. Intervention patients received educational and behavioral interventions by a pharmacist. Primary outcome was the proportion of adherent patients 1 month after discharge. Adherence was a combined measure of self-reported adherence (the 8-item Morisky Medication Adherence Scale) and obtaining repeat prescriptions on time. Secondary outcomes were (1) the proportion of patients adherent to medication; (2) rates of mortality and hospital readmission; and (3) change in quality of life from baseline assessed with the European Quality of Life Questionnaire - 5 Dimensions - 3 Levels at 3 months after discharge. Logistic regression was used to analyze data. Registration: ClinicalTrials.gov (NCT02787941). Results: Overall, 166 patients (87 control, 79 intervention) were included (mean age 61.2 years, 73% male). In the analysis excluding patients from the intervention group who did not receive the intervention and excluding all patients who withdrew, were lost to follow-up, died or were readmitted to hospital, a greater proportion of patients were adherent in the intervention compared with the control at 1 month (90.0% vs. 76.5%; adjusted OR = 2.77; 95% CI, 1.01-7.62) and at 3 months after discharge (90.2% vs. 77.0%; adjusted OR = 3.68; 95% CI, 1.14-11.88). There was no significant difference in median change of EQ-5D-3L index values between intervention and control [0.000 (0.000; 0.275) vs. 0.234 (0.000; 0.379); p = 0.081]. Rates of mortality, readmission, or both were 0.8, 10.3, or 11.1%, respectively; with no significant differences between the 2 groups. Conclusion: Pharmacist-led interventions increased patient adherence to medication regimens by over 13% in the first 3 months after ACS hospital discharge, but not quality of life, mortality and readmission. These results are promising but should be tested in other settings prior to broader dissemination.

Keywords: Vietnam; acute coronary syndrome; medication adherence; pharmacist-led intervention; randomized controlled trial.

Figures

FIGURE 1
FIGURE 1
Flowchart of the study population. ACS, acute coronary syndrome; aPatients who were only excluded from the analysis of adherence 1 month after discharge.

References

    1. Akeroyd J. M., Chan W. J., Kamal A. K., Palaniappan L., Virani S. S. (2015). Adherence to cardiovascular medications in the South Asian population: a systematic review of current evidence and future directions. World J. Cardiol. 7 938–947. 10.4330/wjc.v7.i12.938
    1. Bitton A., Choudhry N. K., Matlin O. S., Swanton K., Shrank W. H. (2013). The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am. J. Med. 126 357.e7–357.e27. 10.1016/j.amjmed.2012.09.004
    1. Bowry A. D., Shrank W. H., Lee J. L., Stedman M., Choudhry N. K. (2011). A systematic review of adherence to cardiovascular medications in resource-limited settings. J. Gen. Intern. Med. 26 1479–1491. 10.1007/s11606-011-1825-3
    1. Brown M. T., Bussell J. K. (2011). Medication adherence: WHO cares? Mayo Clin. Proc. 86 304–314. 10.4065/mcp.2010.0575
    1. Cai H., Dai H., Hu Y., Yan X., Xu H. (2013). Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Serv. Res. 13:461. 10.1186/1472-6963-13-461
    1. Calvert S. B., Kramer J. M., Anstrom K. J., Kaltenbach L. A., Stafford J. A., Allen, et al. (2012). Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am. Heart J. 163 657.e1–665.e1. 10.1016/j.ahj.2012.01.019
    1. Castellano J. M., Sanz G., Penalvo J. L., Bansilal S., Fernandez-Ortiz A., Alvarez L., et al. (2014). A polypill strategy to improve adherence: results from the FOCUS project. J. Am. Coll. Cardiol. 64 2071–2082. 10.1016/j.jacc.2014.08.021
    1. Choudhry N. K., Fischer M. A., Avorn J., Liberman J. N., Schneeweiss S., Pakes J., et al. (2011). The implications of therapeutic complexity on adherence to cardiovascular medications. Arch. Intern. Med. 171 814–822. 10.1001/archinternmed.2010.495
    1. Chowdhury R., Khan H., Heydon E., Shroufi A., Fahimi S., Moore C., et al. (2013). Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur. Heart J. 34 2940–2948. 10.1093/eurheartj/eht295
    1. Community Pharmacy Medicines Management Project Evaluation Team (2007). The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam. Pract. 24 189–200.
    1. Cutrona S. L., Choudhry N. K., Fischer M. A., Servi A., Liberman J. N., Brennan T. A., et al. (2010). Modes of delivery for interventions to improve cardiovascular medication adherence. Am. J. Manag. Care 16 929–942.
    1. Dugani S., Gaziano T. A. (2016). 25 by 25: Achieving global reduction in cardiovascular mortality. Curr. Cardiol. Rep. 18:10. 10.1007/s11886-015-0679-4
    1. EuroQol Group (2015). EQ-5D-3L user Guide Basic Information on How to use the EQ-5D-3L Instrument. Rotterdam: EuroQol Group.
    1. Folstein M. F., Folstein S. E., McHugh P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 189–198. 10.1016/0022-3956(75)90026-6
    1. GBD 2015 DALYs and HALE Collaborators (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 1603–1658. 10.1016/S0140-6736(16)31460-X
    1. Ho P. M., Lambert-Kerzner A., Carey E. P., Fahdi I. E., Bryson C. L., Melnyk S. D., et al. (2014). Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern. Med. 174 186–193. 10.1001/jamainternmed.2013.12944
    1. Horne R., Weinman J., Barber N., Elliott R. A., Morgan M. (2005). Concordance, Adherence and Compliance in Medicine Taking: Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). London: NCCSDO.
    1. Horne R., Weinman J., Hankins M. (1999). The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol. Health 14 1–24. 10.1080/08870449908407311
    1. Kang J. E., Han N. Y., Oh J. M., Jin H. K., Kim H. A., Son I. J., et al. (2016). Pharmacist-involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta-analysis. J. Clin. Pharm. Ther. 41 145–157. 10.1111/jcpt.12367
    1. Khonsari S., Subramanian P., Chinna K., Latif L. A., Ling L. W., Gholami O. (2015). Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur. J. Cardiovasc. Nurs. 14 170–179. 10.1177/1474515114521910
    1. Koshman S. L., Charrois T. L., Simpson S. H., McAlister F. A., Tsuyuki R. T. (2008). Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch. Intern. Med. 168 687–694. 10.1001/archinte.168.7.687
    1. Leggett A., Zarit S. H., Hoang C. N., Nguyen H. T. (2013). Correlates of cognitive impairment in older Vietnamese. Aging Ment. Health 17 915–923. 10.1080/13607863.2013.799116
    1. Lourenco L. B., Rodrigues R. C., Ciol M. A., Sao-Joao T. M., Cornelio M. E., Dantas R. A., et al. (2014). A randomized controlled trial of the effectiveness of planning strategies in the adherence to medication for coronary artery disease. J. Adv. Nurs. 70 1616–1628. 10.1111/jan.12323
    1. Moran A. E., Forouzanfar M. H., Roth G. A., Mensah G. A., Ezzati M., Murray C. J., et al. (2014). Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the global burden of disease 2010 study. Circulation 129 1483–1492. 10.1161/CIRCULATIONAHA.113.004042
    1. Morisky D. E., Ang A., Krousel-Wood M., Ward H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. 10 348–354. 10.1111/j.1751-7176.2008.07572.x
    1. Nguyen H. T., Pham H. T., Vo D. K., Nguyen T. D., van den Heuvel E. R., Haaijer-Ruskamp F. M., et al. (2014). The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Qual. Saf. 23 319–324. 10.1136/bmjqs-2013-002357
    1. Nguyen T., Nguyen T. H., Cao H. T. K., Le K. K., Pham S. T., Pham H. T. K., et al. (2016). Patient Adherence to treatment after discharge for acute coronary syndrome in vietnam: a prospective observational study. Pharmacoepidemiol. Drug Saf. 25:184.
    1. Nguyen T., Nguyen T. H., Pham S. T., Cao H. T., Le K. K., Pham H. T., et al. (2015). Translation and cross-cultural adaptation of the brief illness perception questionnaire, the beliefs about medicines questionnaire and the Morisky Medication Adherence Scale into Vietnamese. Pharmacoepidemiol. Drug Saf. 24 159–160. 10.1002/pds.3838
    1. Oliveira-Filho A. D., Morisky D. E., Costa F. A., Pacheco S. T., Neves S. F., Lyra-Jr D. P. (2014). Improving post-discharge medication adherence in patients with CVD: a pilot randomized trial. Arq. Bras. Cardiol. 103 503–512. 10.5935/abc.20140151
    1. Rinfret S., Rodes-Cabau J., Bagur R., Dery J. P., Dorais M., Larose E., et al. (2013). Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation. Heart 99 562–569. 10.1136/heartjnl-2012-303004
    1. Santo K., Kirkendall S., Laba T. L., Thakkar J., Webster R., Chalmers J., et al. (2016). Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials. Eur. J. Prev. Cardiol. 23 1065–1076. 10.1177/2047487316638501
    1. Santschi V., Chiolero A., Burnand B., Colosimo A. L., Paradis G. (2011). Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch. Intern. Med. 171 1441–1453. 10.1001/archinternmed.2011.399
    1. Simpson S. H., Eurich D. T., Majumdar S. R., Padwal R. S., Tsuyuki R. T., Varney J., et al. (2006). A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333:15. 10.1136/bmj.38875.675486.55
    1. Tuoi Tre News (2015). Ho Chi Minh City Heart Institute Saves Lives with French Association Support. Ho Chi Minh: Tuoi Tre News.
    1. Vietnam Ministry of Health (2013). Vietnam Health Statistical Profile 2009–2013. Hà Nôi: Vietnam Ministry of Health.
    1. Vo T. H., Bedouch P., Nguyen T. H., Nguyen T. L., Hoang T. K., Calop J., et al. (2013). Pharmacy education in Vietnam. Am. J. Pharm. Educ. 77:114. 10.5688/ajpe776114
    1. World Health Organization (2016). International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for 2016. Geneva: World Health Organization.
    1. World Health Organization (2017a). Prevention of Recurrences of Myocardial Infarction and Stroke Study (The PREMISE programme: Country project. Geneva: World Health Organization.
    1. World Health Organization (2017b). The Top 10 Causes of Death. 2017. Geneva: World Health Organization.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit